Patent details

EP2959918 Title: ANTI-MALIGNANT TUMOR AGENT COMPOSITION

Basic Information

Publication number:
EP2959918
PCT Application Number:
JP2014065163
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP148092687
PCT Publication Number:
WO2015173970
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-MALIGNANT TUMOR AGENT COMPOSITION
French Title of Invention:
COMPOSITION D'AGENT ANTI-TUMEUR MALIGNE
German Title of Invention:
ZUSAMMENSETZUNG FÜR ANTIKREBSMITTEL
SPC Number:

Dates

Filing date:
07/06/2014
Grant date:
22/05/2019
EP Publication Date:
30/12/2015
PCT Publication Date:
19/11/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
22/05/2019
EP B1 Publication Date:
22/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
07/06/2019
Expiration date:
07/06/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
15/05/2019
 
 

Name:
J-Pharma Co., Ltd.
Address:
75-1 Onocho Tsurumi-ku Yokohama-shi, Kanagawa 230-0046, Japan (JP)

Inventor

1

Name:
PEYRON, Jean-Francois
Address:
France (FR)

2

Name:
ENDOU, Hitoshi
Address:
Japan (JP)

3

Name:
ANZAI, Naohiko
Address:
Japan (JP)

4

Name:
JUTABHA, Promsuk
Address:
Japan (JP)

5

Name:
WEMPE, Michael F.
Address:
United States (US)

Priority

Priority Number:
1454362
Priority Date:
15/05/2014
Priority Country:
France (FR)

Classification

IPC classification:
A61K 31/282; A61K 31/416; A61K 31/423; A61K 31/436; A61K 31/5377; A61K 31/69; A61K 31/704; A61K 31/7068; A61P 35/00; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
201921
Publication date:
22/05/2019
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages